Each Halloween, poison centers in the United States see a spike in the number of calls about glow products such as glow ...

WHILE attributing the ongoing slump in the local stock market to the flood control corruption scandal, the heads of regulatory agencies should look first in their own backyard.

Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...

Flowserve shows renewed growth with a rising backlog, asbestos resolution, and strong 22% return potential. Learn why FLS ...

Here's why there's a good chance this growth stock triples over the next two years and becomes a top stock by the end of 2027 ...

UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround ...

Developments outside of Ford's control knocked the quarter, but investors shouldn't ignore the strong numbers.

Mark Zuckerberg’s Meta is spending untold billions on infrastructure and top talent for its AI ambitions. In fact, the CEO ...

Key Insights Given the large stake in the stock by institutions, Credo Technology Group Holding's stock price might ...

Bengaluru-based Triton Valves is a small company with a long history of making valves. The stock has compounded 33% annually ...

As of September 30, select Indian mutual fund schemes - both active and passive - continued to maintain exposure to Nvidia, ...

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...